Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials

<div><i>Forest plots of cerebrolysin administration and mRS at endpoint</i>. (a) Subgroup analysis of dichotomous data for mRS defined by time widow of intervention. (b) Overall analysis of continuous data for mRS. CI, confidence interval; RR, risk ratio; WMD, weighted mean difference; mRS, modified Rankin Scale.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials 